Annual Operating Profit
-$15.89 M
-$4.47 M-39.13%
31 December 2023
Summary:
NeuroBo Pharmaceuticals annual operaing income is currently -$15.89 million, with the most recent change of -$4.47 million (-39.13%) on 31 December 2023. During the last 3 years, it has fallen by -$588.00 thousand (-3.84%). NRBO annual operating profit is now -5872.18% below its all-time high of -$266.00 thousand, reached on 31 December 2014.NRBO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$6.26 M
+$3.83 M+37.93%
30 September 2024
Summary:
NeuroBo Pharmaceuticals quarterly operating income is currently -$6.26 million, with the most recent change of +$3.83 million (+37.93%) on 30 September 2024. Over the past year, it has dropped by -$592.00 thousand (-10.45%). NRBO quarterly operating profit is now -255.77% below its all-time high of $4.02 million, reached on 31 December 2018.NRBO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$28.89 M
-$2.37 M-8.92%
30 September 2024
Summary:
NeuroBo Pharmaceuticals TTM operating income is currently -$28.89 million, with the most recent change of -$2.37 million (-8.92%) on 30 September 2024. Over the past year, it has dropped by -$13.01 million (-81.86%). NRBO TTM operating profit is now -1718.19% below its all-time high of -$1.59 million, reached on 31 March 2015.NRBO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRBO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -10.4% | -81.9% |
| 3 y3 years | -3.8% | -36.7% | -88.8% |
| 5 y5 years | +21.3% | +48.7% | -43.2% |
NRBO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -39.1% | at low | -181.9% | +37.9% | -161.2% | at low |
| 5 y | 5 years | -39.1% | +46.5% | -181.9% | +67.9% | -161.2% | +4.5% |
| alltime | all time | -5872.2% | +52.0% | -255.8% | +67.9% | -1718.2% | +14.5% |
NeuroBo Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.26 M(-37.9%) | -$28.89 M(+8.9%) |
| June 2024 | - | -$10.08 M(+46.5%) | -$26.52 M(+31.0%) |
| Mar 2024 | - | -$6.88 M(+21.4%) | -$20.25 M(+27.5%) |
| Dec 2023 | -$15.89 M(+39.1%) | -$5.67 M(+45.6%) | -$15.89 M(+27.7%) |
| Sept 2023 | - | -$3.89 M(+2.3%) | -$12.44 M(+6.8%) |
| June 2023 | - | -$3.81 M(+51.0%) | -$11.65 M(+5.3%) |
| Mar 2023 | - | -$2.52 M(+13.5%) | -$11.06 M(-3.1%) |
| Dec 2022 | -$11.42 M(-25.4%) | -$2.22 M(-28.5%) | -$11.42 M(-17.1%) |
| Sept 2022 | - | -$3.10 M(-3.6%) | -$13.78 M(-2.5%) |
| June 2022 | - | -$3.22 M(+12.0%) | -$14.14 M(-4.8%) |
| Mar 2022 | - | -$2.88 M(-37.2%) | -$14.84 M(-3.0%) |
| Dec 2021 | -$15.30 M(-48.5%) | -$4.58 M(+32.2%) | -$15.30 M(-49.4%) |
| Sept 2021 | - | -$3.46 M(-11.8%) | -$30.23 M(+1.4%) |
| June 2021 | - | -$3.93 M(+17.9%) | -$29.83 M(+5.4%) |
| Mar 2021 | - | -$3.33 M(-82.9%) | -$28.30 M(-4.8%) |
| Dec 2020 | -$29.72 M(+47.3%) | -$19.52 M(+537.7%) | -$29.72 M(+32.7%) |
| Sept 2020 | - | -$3.06 M(+27.9%) | -$22.39 M(-2.5%) |
| June 2020 | - | -$2.39 M(-49.6%) | -$22.98 M(+2.2%) |
| Mar 2020 | - | -$4.75 M(-61.1%) | -$22.47 M(+11.4%) |
| Dec 2019 | -$20.18 M | -$12.19 M(+234.5%) | -$20.18 M(+408.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | -$3.65 M(+93.2%) | -$3.96 M(-36.3%) |
| June 2019 | - | -$1.89 M(-23.0%) | -$6.23 M(-42.7%) |
| Mar 2019 | - | -$2.45 M(-161.0%) | -$10.87 M(-29.8%) |
| Dec 2018 | -$15.49 M(-53.2%) | $4.02 M(-168.0%) | -$15.49 M(-40.6%) |
| Sept 2018 | - | -$5.91 M(-9.6%) | -$26.07 M(-9.2%) |
| June 2018 | - | -$6.53 M(-7.5%) | -$28.70 M(-12.2%) |
| Mar 2018 | - | -$7.06 M(+7.6%) | -$32.69 M(-1.3%) |
| Dec 2017 | -$33.12 M(+125.4%) | -$6.57 M(-23.1%) | -$33.12 M(-2.0%) |
| Sept 2017 | - | -$8.54 M(-18.8%) | -$33.78 M(+17.9%) |
| June 2017 | - | -$10.52 M(+40.1%) | -$28.65 M(+43.4%) |
| Mar 2017 | - | -$7.50 M(+3.8%) | -$19.97 M(+35.9%) |
| Dec 2016 | -$14.70 M(+105.0%) | -$7.23 M(+112.5%) | -$14.70 M(+47.3%) |
| Sept 2016 | - | -$3.40 M(+84.9%) | -$9.98 M(+11.6%) |
| June 2016 | - | -$1.84 M(-17.3%) | -$8.94 M(+2.6%) |
| Mar 2016 | - | -$2.23 M(-11.4%) | -$8.71 M(+7.9%) |
| Dec 2015 | -$7.17 M(+2594.7%) | -$2.51 M(+6.1%) | -$8.08 M(+45.1%) |
| Sept 2015 | - | -$2.37 M(+47.0%) | -$5.57 M(+74.0%) |
| June 2015 | - | -$1.61 M(+1.3%) | -$3.20 M(+101.3%) |
| Mar 2015 | - | -$1.59 M | -$1.59 M |
| Dec 2014 | -$266.00 K | - | - |
FAQ
- What is NeuroBo Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly operating profit year-on-year change?
- What is NeuroBo Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals TTM operating profit year-on-year change?
What is NeuroBo Pharmaceuticals annual operaing income?
The current annual operating profit of NRBO is -$15.89 M
What is the all time high annual operating profit for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual operaing income is -$266.00 K
What is NeuroBo Pharmaceuticals quarterly operating income?
The current quarterly operating profit of NRBO is -$6.26 M
What is the all time high quarterly operating profit for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly operating income is $4.02 M
What is NeuroBo Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, NRBO quarterly operating income has changed by -$592.00 K (-10.45%)
What is NeuroBo Pharmaceuticals TTM operating income?
The current TTM operating profit of NRBO is -$28.89 M
What is the all time high TTM operating profit for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high TTM operating income is -$1.59 M
What is NeuroBo Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, NRBO TTM operating income has changed by -$13.01 M (-81.86%)